Dorval Allison's Form 4 filing
Puma Biotechnology, Inc. (PBYI) · filed Jun 15, 2023
- Accession no.
- 0001437749-23-017604
- Filed
- Jun 15, 2023
- Trade date
- Jun 13, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $34.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dorval AllisonCIK 0001625110 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2023 | Common Stock | SSaleDisposed | −10,000 | $3.45 | −$34,500 | 17,000 | Direct | |
| Jun 13, 2023 | Common Stock | AGrant or awardAcquired | +27,000 | $0.00 | $0 | 44,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.